Rovalpituzumab (Anti-DLL3)
Product Specifications
CAS Number
1613313-01-1
Additionnal Information
Rovalpituzumab (Anti-DLL3) is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3) . Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC) . MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC473082-100 1x 100 µL
Cathepsin D (Tumor Marker) (CTSD/3082), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
